Mohammad Abu Zaid
- Biochemistry top 2%
- Dermatology top 2%
- Skin Protection and Aging 4
- Hematology top 5%
- Multiple Myeloma Research and Treatments 12
- Hematopoietic Stem Cell Transplantation 7
- Acute Myeloid Leukemia Research 5
- Toxicology top 5%
- Reproductive Medicine top 10%
-
- Testicular diseases and treatments 12
-
- CAR-T cell therapy research 5
- Peptidase Inhibition and Analysis 4
-
- Immune Cell Function and Interaction 5
- Co-authors
- Hasan MukhtarFarrukh AfaqNaghma KhanDeeba N. SyedMark L. DreherMohammad AsimLawrence H. EinhornSami Sarfaraz
- Cited by
- BiochemistryDermatologyHematology
- Journals
- New England Journal of Medicine (1 paper)Nature Communications (1 paper)Journal of Clinical Oncology (2 papers)
- Partner nations
- United StatesIndiaChina
In The Last Decade
Mohammad Abu Zaid
57 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 121
- Biochemistry 272
- Dermatology 279
- Hematology 234
- Toxicology 41
- Reproductive Medicine 88
Countries citing papers authored by Mohammad Abu Zaid
This map shows the geographic impact of Mohammad Abu Zaid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammad Abu Zaid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammad Abu Zaid more than expected).
Fields of papers citing papers by Mohammad Abu Zaid
This network shows the impact of papers produced by Mohammad Abu Zaid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammad Abu Zaid. The network helps show where Mohammad Abu Zaid may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mohammad Abu Zaid, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 3 | |
| 3 | 2023 | 6 | |
| 4 | 2023 | 2 | |
| 5 | 2023 | 8 | |
| 6 | 2022 | 24 | |
| 7 | 2021 | 25 | |
| 8 | 2021 | 10 | |
| 9 | 2021 | 10 | |
| 10 | 2021 | 13 | |
| 11 | 2020 | 0 | |
| 12 | Multi-Institutional Assessment of Adverse Health Outcomes Among North American Testicular Cancer Survivors After Modern Cisplatin-Based Chemotherapy | 2017 | 1 |
| 13 | 2017 | 142 | |
| 14 | 2016 | 89 | |
| 15 | 2015 | 59 | |
| 16 | 2009 | 155 | |
| 17 | Inhibitory effect of oral feeding of pomegranate fruit extract on UVB-induced skin carcinogenesis in SKH-1 hairless mice | 2008 | 4 |
| 18 | Exposure of normal human epidermal keratinocytes to ozone results in increased expression of cytochrome P450 through activation of aryl hydrocarbon receptor | 2008 | 1 |
| 19 | 2007 | 95 | |
| 20 | 2006 | 193 |
About Mohammad Abu Zaid
Mohammad Abu Zaid is a scholar working on Hematology, Reproductive Medicine and Oncology, having authored 59 papers that have together received 1.7k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (12 papers), Testicular diseases and treatments (12 papers), Hematopoietic Stem Cell Transplantation (7 papers), Acute Myeloid Leukemia Research (5 papers), CAR-T cell therapy research (5 papers), Immune Cell Function and Interaction (5 papers), Peptidase Inhibition and Analysis (4 papers) and Skin Protection and Aging (4 papers). The work is most often cited by research in Biochemistry (272 citations), Dermatology (279 citations) and Hematology (234 citations). Mohammad Abu Zaid has collaborated with scholars based in United States, India and China. Frequent co-authors include Hasan Mukhtar, Farrukh Afaq, Naghma Khan, Deeba N. Syed, Mark L. Dreher, Mohammad Asim, Lawrence H. Einhorn, Sami Sarfaraz, Michal Chovanec and Costantine Albany. Their work appears in journals such as New England Journal of Medicine, Nature Communications and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.